The bispecific innate cell engager AFM28 eliminates CD123 leukemic stem and progenitor cells in AML and MDS

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-63069-y
Affiliations:
3
Authors:
22
Go to article
Institutions Authors Share
Affimed Therapeutics AG, Germany
13.000000
13.000000
 0.59
Heidelberg University (Uni Heidelberg), Germany
9.000000
 0.41
Interested in Oncology and Carcinogenesis?